192 related articles for article (PubMed ID: 24001451)
21. Interleukin-15 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).
Leroy S; Dubois S; Tenaud I; Chebassier N; Godard A; Jacques Y; Dréno B
Br J Dermatol; 2001 May; 144(5):1016-23. PubMed ID: 11359391
[TBL] [Abstract][Full Text] [Related]
22. Serum mucosa-associated epithelial chemokine (MEC/CCL28) in atopic dermatitis: a specific marker for severity.
Ezzat MH; Sallam MA; Shaheen KY
Int J Dermatol; 2009 Aug; 48(8):822-9. PubMed ID: 19659860
[TBL] [Abstract][Full Text] [Related]
23. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
24. IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma.
Miyagaki T; Sugaya M; Suga H; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Clin Cancer Res; 2011 Dec; 17(24):7529-38. PubMed ID: 22048239
[TBL] [Abstract][Full Text] [Related]
25. Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma.
Wong HK
Discov Med; 2013 Sep; 16(87):71-8. PubMed ID: 23998443
[TBL] [Abstract][Full Text] [Related]
26. Romidepsin and total skin electron beam therapy in advanced stage mycosis fungoides and Sézary syndrome.
Jothishankar B; Almazan T; Kim Y; Liauw S; Smith S; Kline J; Abdulla F
Br J Haematol; 2019 Jul; 186(2):377-379. PubMed ID: 30937886
[No Abstract] [Full Text] [Related]
27. BAFF levels are increased in lesional skin and sera in patients with cutaneous T-cell lymphoma.
Ohmatsu H; Sugaya M; Miyagaki T; Suga H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Br J Dermatol; 2012 Aug; 167(2):359-67. PubMed ID: 22512719
[TBL] [Abstract][Full Text] [Related]
28. Presence of circulating CCR10+ T cells and elevated serum CTACK/CCL27 in the early stage of mycosis fungoides.
Fujita Y; Abe R; Sasaki M; Honda A; Furuichi M; Asano Y; Norisugi O; Shimizu T; Shimizu H
Clin Cancer Res; 2006 May; 12(9):2670-5. PubMed ID: 16675558
[TBL] [Abstract][Full Text] [Related]
29. Increased serum thymus and activation-regulated chemokine and cutaneous T cell-attracting chemokine levels in children with atopic dermatitis.
Song TW; Sohn MH; Kim ES; Kim KW; Kim KE
Clin Exp Allergy; 2006 Mar; 36(3):346-51. PubMed ID: 16499646
[TBL] [Abstract][Full Text] [Related]
30. Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxin-3/CCL26 levels reflect the disease activity of atopic dermatitis.
Kagami S; Kakinuma T; Saeki H; Tsunemi Y; Fujita H; Nakamura K; Takekoshi T; Kishimoto M; Mitsui H; Torii H; Komine M; Asahina A; Tamaki K
Clin Exp Immunol; 2003 Nov; 134(2):309-13. PubMed ID: 14616792
[TBL] [Abstract][Full Text] [Related]
31. Nocturnal wrist movements are correlated with objective clinical scores and plasma chemokine levels in children with atopic dermatitis.
Hon KL; Lam MC; Leung TF; Kam WY; Lee KC; Li MC; Fok TF; Ng PC
Br J Dermatol; 2006 Apr; 154(4):629-35. PubMed ID: 16536804
[TBL] [Abstract][Full Text] [Related]
32. Paucity of intraepidermal FoxP3-positive T cells in cutaneous T-cell lymphoma in contrast with spongiotic and lichenoid dermatitis.
Wada DA; Wilcox RA; Weenig RH; Gibson LE
J Cutan Pathol; 2010 May; 37(5):535-41. PubMed ID: 19674197
[TBL] [Abstract][Full Text] [Related]
33. Serum amyloid A levels in the blood of patients with atopic dermatitis and cutaneous T-cell lymphoma.
Suzuki H; Sugaya M; Nakajima R; Oka T; Takahashi N; Nakao M; Miyagaki T; Asano Y; Sato S
J Dermatol; 2018 Dec; 45(12):1440-1443. PubMed ID: 30289574
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous T-cell lymphoma.
Lansigan F; Choi J; Foss FM
Hematol Oncol Clin North Am; 2008 Oct; 22(5):979-96, x. PubMed ID: 18954747
[TBL] [Abstract][Full Text] [Related]
35. A modified staging classification for cutaneous T-cell lymphoma.
Kashani-Sabet M; McMillan A; Zackheim HS
J Am Acad Dermatol; 2001 Nov; 45(5):700-6. PubMed ID: 11606919
[TBL] [Abstract][Full Text] [Related]
36. Myocosis fungoides--an update on a non-mycotic disease.
Makdisi J; Friedman A
J Drugs Dermatol; 2013 Jul; 12(7):825-31. PubMed ID: 23884501
[TBL] [Abstract][Full Text] [Related]
37. Placental Growth Factor and Vascular Endothelial Growth Factor Together Regulate Tumour Progression via Increased Vasculature in Cutaneous T-cell Lymphoma.
Miyagaki T; Sugaya M; Oka T; Takahashi N; Kawaguchi M; Suga H; Fujita H; Yoshizaki A; Asano Y; Sato S
Acta Derm Venereol; 2017 May; 97(5):586-592. PubMed ID: 28119994
[TBL] [Abstract][Full Text] [Related]
38. High numbers of DC-SIGN+ dendritic cells in lesional skin of cutaneous T-cell lymphoma.
Schlapbach C; Ochsenbein A; Kaelin U; Hassan AS; Hunger RE; Yawalkar N
J Am Acad Dermatol; 2010 Jun; 62(6):995-1004. PubMed ID: 20466174
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous T cell lymphomas: mycosis fungoides, Sézary syndrome and lymphomatoid papulosis--Part I.
Safai B
Clin Bull; 1977; 7(3):91-7. PubMed ID: 308870
[No Abstract] [Full Text] [Related]
40. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.
Hijnen D; De Bruin-Weller M; Oosting B; Lebre C; De Jong E; Bruijnzeel-Koomen C; Knol E
J Allergy Clin Immunol; 2004 Feb; 113(2):334-40. PubMed ID: 14767451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]